Chlamydia infection screening: Difference between revisions
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
*Consider screening young men in high prevalence clinical settings or in populations with high burden of infection (e.g. MSM) | *Consider screening young men in high prevalence clinical settings or in populations with high burden of infection (e.g. MSM) | ||
*At least annually for sexually active men who have sex with men (MSM) and then very 3 to 6 months if at increased risk | *At least annually for sexually active men who have sex with men (MSM) and then very 3 to 6 months if at increased risk | ||
===Individuals with HIV=== | |||
*For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter | |||
*More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology | |||
==References== | ==References== | ||
Revision as of 21:01, 6 January 2016
|
Chlamydia infection Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chlamydia infection screening On the Web |
|
American Roentgen Ray Society Images of Chlamydia infection screening |
|
Risk calculators and risk factors for Chlamydia infection screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2]
Overview
According to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC, screening for chlamydia is recommended.[1]
Screening
According to the 2015 Sexually Transmitted Diseases Treatment Guidelines by the CDC, screening for chlamydia is recommended. The guidelines are as follows:[1]
Women
- Sexually active women under 25 years of age
- Sexually active women aged 25 years and older if at increased risk
- Retest approximately 3 months after treatment
Pregnant Women
- All pregnant women under 25 years of age
- Pregnant women, aged 25 and older if at increased risk
- Retest during the 3rd trimester for women under 25 years of age or at risk
Men
- Consider screening young men in high prevalence clinical settings or in populations with high burden of infection (e.g. MSM)
- At least annually for sexually active men who have sex with men (MSM) and then very 3 to 6 months if at increased risk
Individuals with HIV
- For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter
- More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology
References
- ↑ 1.0 1.1 Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016